首页> 外文期刊>NeuroImage: Clinical >Spatiotemporal EEG microstate analysis in drug-free patients with Parkinson's disease
【24h】

Spatiotemporal EEG microstate analysis in drug-free patients with Parkinson's disease

机译:不含药物患者的帕金森病患者的时尚脑脑电图分析

获取原文
           

摘要

The clinical diagnosis of Parkinson's disease (PD) is very difficult, especially in the early stage of the disease, because there is no physiological indicator that can be referenced. Drug-free patients with early PD are characterized by clinical symptoms such as impaired motor function and cognitive decline, which was caused by the dysfunction of brain's dynamic activities. The indicators of brain dysfunction in patients with PD at an early unmedicated condition may provide a valuable basis for the diagnosis of early PD and later treatment. In order to find the spatiotemporal characteristic markers of brain dysfunction in PD, the resting-state EEG microstate analysis is used to explore the transient state of the whole brain of 23 drug-free patients with PD on the sub-second timescale compared to 23 healthy controls. EEG microstates reflect a transiently stable brain topological?structure with spatiotemporal characteristics, and the spatial characteristic microstate classes and temporal parameters provide insight into the brain's functional activities in PD patients. The further exploration was to explore the relation between temporal microstate parameters and significant clinical symptoms to determine whether these parameters could be used as a basis for clinically assisted diagnosis. Therefore, we used a general linear model (GLM) to explore the relevance of microstate parameters to clinical scales and multiple patient attributes, and the Wilcoxon?rank sum?test was used to quantify the linear relation between influencing factors and microstate parameters. Results of microstate analysis revealed that there was an unique spatial microstate different from healthy controls in PD, and several other typical microstates had significant differences compared with the normal control group, and these differences were reflected in the microstate parameters, such as longer durations and more occurrences of one class of microstates in PD compared with healthy controls. Furthermore, correlation analysis showed that there was a significant correlation between multiple microstate classes’ parameters and significant clinical symptoms, including impaired motor function and cognitive decline. These results indicate that we have found multiple quantifiable feature tags that reflect brain dysfunction in the early stage of PD. Importantly, such temporal dynamics in microstates are correlated with clinical scales which represent the motor function and recognize level. The obtained results may deepen our understanding of the brain dysfunction caused by PD, and obtain some quantifiable signatures to provide an auxiliary reference for the early diagnosis of PD.
机译:帕金森病(PD)的临床诊断非常困难,特别是在疾病的早期阶段,因为没有能够引用的生理指标。无毒患者早期PD的特征是临床症状,如运动功能受损和认知下降,这是由大脑动态活动的功能障碍引起的。在早期未描述的条件下PD患者脑功能障碍的指标可以为早期PD和后期治疗的诊断提供有价值的基础。为了找到Pd中脑功能障碍的时空特征标记,静止状态EEG微溶液分析用于探索23例无毒患者的全部脑的瞬态状态,与23次健康相比,在第二次少量尺寸上探讨了PD的23名无毒患者的肺部患者控制。 EEG Microstates反映了一种瞬时稳定的脑拓扑α结构,具有时空特性,并且空间特征微溶液类和时间参数提供了对PD患者的大脑功能活动的洞察力。进一步的探索是探讨时间微溶液参数与显着临床症状之间的关系,以确定这些参数是否可以用作临床辅助诊断的基础。因此,我们使用了一般的线性模型(GLM)来探讨微溶液参数对临床尺度和多个患者属性的相关性,以及威尔克森?秩和α试验用于量化影响因素和微溶液参数之间的线性关系。微酸分析结果显示,与Pd中的健康对照有不同的空间微溶液,与正常对照组相比,几种其他典型的微溶液具有显着的差异,并且这些差异反映在微溶液参数中,例如更长的持续时间和更多与健康对照相比,Pd中一类微生物的发生。此外,相关性分析表明,多种微溶液类参数与显着的临床症状之间存在显着相关性,包括运动功能受损和认知下降。这些结果表明,我们已经发现了多种可量化的特征标签,其反映了PD的早期阶段的脑功能障碍。重要的是,Microstate中的这种时间动态与表示电机功能和识别水平的临床尺度相关。获得的结果可以加深我们对PD引起的脑功能障碍的理解,并获得一些可量化的签名,以提供PD早期诊断的辅助参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号